Grants Awarded

Infrastructure Grants

Funds provided by the Cancer Institute New South Wales and Cancer Australia to support ANZUP infrastructure are managed by the University of Sydney NHMRC Clinical Trials Centre and therefore not reported in the financial accounts of ANZUP unless transferred in support of specific expenses incurred by ANZUP . Grants contributing to ANZUP infrastructure costs during the 2012- 2013 period are outlined below .

Funding

Cancer Australia Infrastructure Grant: 1 July 2010 to 30 June 2013 - $1,394,826 was awarded to ANZUP and the NHMRC Clinical Trials Centre . During this reporting period $144,466 was transferred to ANZUP and was reported in the 2012 Annual Accounts .

Cancer Institute NSW Infrastructure Grant: 1 January 2013 to 1 January 2016 was awarded to ANZUP and the NHMRC Clinical Trials Centre - $300,000 .

Research Grants

Funds provided by Cancer Australia, the National Health and Medical Research Council, the Cancer Institute NSW and other bodies in support of trial coordination are also managed by the University of Sydney NHRMC Clinical Trials centre and therefore are not reported in the financial accounts of ANZUP .

Grants awarded to ANZUP Cancer Trials Group during this reporting period are listed below:

SORCE: A phase III randomised double-blind study comparing sorafenib with placebo in patients with resected primary renal cell carcinoma at high or intermediate risk of relapse . Funding Medical Research Council, United Kingdom $820,000: 2009-2017

EVERSUN: A phase II trial of EVERolimus alternating with SUNitinib as first line therapy for advanced renal cell carcinoma . Funding Novartis $1,053,318: 2010-2013

BCG+MMC: Adding mitomycin C to BCG as adjuvant intravesical therapy for high-risk, non–muscle-invasive bladder cancer: a randomised phase III trial . Funding Cancer Australia $457,143 .17: 2013-2016 .

Phase III Accelerated BEP (Cancer Australia): A randomised trial of accelerated versus standard BEP chemotherapy for intermediate and poor-risk advanced germ cell tumours . Funding Cancer Australia $595,342 .48: 2013-2016

ANZUP GRANTS MANAGED BY NHMRC CTC UP TO 31 MARCH, 2013

$1,200,000

$1,000,000

AMOUNT IN DOLLARS $800,000

$600,000

$400,000

$200,000

$0

2009 2010 2011 2012 2013